Skip to main content
PMC home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1971;45(6):719–732.

WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients*

C G S Iyer, J Languillon, K Ramanujam, G Tarabini-Castellani, J Terencio de las Aguas, L M Bechelli, K Uemura, V Martinez Dominguez, T Sundaresan
PMCID: PMC2427977  PMID: 4947831

Abstract

The treatment of lepra reactions constitutes one of the most serious problems in leprosy. For this reason, the first reports in 1965 of the favourable results obtained with thalidomide aroused considerable interest and led WHO, in 1967, to carry out a trial with the co-operation of four centres. A short-term double-blind trial was designed to study the effect of thalidomide, in comparison with acetylsalicylic acid, in the treatment of acute lepra reactions in male lepromatous patients. Acetylsalicylic acid was used instead of a placebo because of its antipyretic and analgesic activity. Because of the severe adverse reactions that may be caused by thalidomide, mainly the teratogenic effects, only males were included in the trial.

The results of this short-term study seem to confirm previous reports of the efficacy of thalidomide and indicate that acetylsalicylic acid also seems to be helpful in the management of certain symptoms of lepra reactions.

Full text

PDF
719

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cazort R. J., Ye Kun Song A trial of thalidomide in progressive lepra reactions. Curr Ther Res Clin Exp. 1966 Jun;8(6):299–311. [PubMed] [Google Scholar]
  2. Languillon J., Klein J. M., Giraudeau P. Traitement de la réaction lépreuse à type d'érythème noueux par la thalidomide (N-phtalimidoglutarimide) Bull Soc Med Afr Noire Lang Fr. 1968;13(1):116–118. [PubMed] [Google Scholar]
  3. Opromolla D. V., Lima L. S., Marques M. B. A talidomida nos surtos agudos da lepra (eritema nodoso ou polimorfo) Hospital (Rio J) 1966 Apr;69(4):827–844. [PubMed] [Google Scholar]
  4. SHESKIN J. THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS. Clin Pharmacol Ther. 1965 May-Jun;6:303–306. doi: 10.1002/cpt196563303. [DOI] [PubMed] [Google Scholar]
  5. Sheskin J., Convit J. Results of a double blind study of the influence of thalidomide on the lepra reaction. Int J Lepr Other Mycobact Dis. 1969 Apr-Jun;37(2):135–146. [PubMed] [Google Scholar]
  6. Sheskin J. Further observation with thalidomide in lepra reactions. Lepr Rev. 1965 Oct;36(4):183–187. doi: 10.5935/0305-7518.19650036. [DOI] [PubMed] [Google Scholar]
  7. Sheskin J. Recent experience with thalidomide in Hansen's Disease. Int J Dermatol. 1970 Jan-Mar;9(1):56–58. doi: 10.1111/j.1365-4362.1970.tb04730.x. [DOI] [PubMed] [Google Scholar]
  8. Sheskin J. Therapie der Lepra-Reaktion mit Thalidomid. (Eine Doppelblind-Studie). Vorläufige Mitteilung. Hautarzt. 1966 Dec;17(12):548–549. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES